HCA Healthcare Files 8-K

Ticker: HCA · Form: 8-K · Filed: Oct 27, 2025 · CIK: 860730

Sentiment: neutral

Topics: 8-k, filing, financials

Related Tickers: HCA

TL;DR

HCA Healthcare filed an 8-K on 10/27/25 - details pending.

AI Summary

HCA Healthcare, Inc. filed an 8-K on October 27, 2025, reporting other events and financial statements/exhibits. The filing does not contain specific details about the nature of these events or financial figures within the provided text.

Why It Matters

This filing indicates HCA Healthcare is reporting significant events or financial updates to the SEC, which could impact investors' understanding of the company's current status.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report without immediate negative or positive disclosures in the provided text.

Key Players & Entities

FAQ

What specific 'Other Events' are being reported by HCA Healthcare?

The provided text of the 8-K filing does not specify the nature of the 'Other Events' being reported.

What financial statements or exhibits are included in this filing?

The filing indicates that 'Financial Statements and Exhibits' are included, but the specific content is not detailed in the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on October 27, 2025.

What is HCA Healthcare's principal executive office address?

HCA Healthcare's principal executive office is located at One Park Plaza, Nashville, Tennessee 37203.

What is the Commission File Number for HCA Healthcare?

The Commission File Number for HCA Healthcare is 001-11239.

Filing Stats: 844 words · 3 min read · ~3 pages · Grade level 12.5 · Accepted 2025-10-27 16:16:44

Key Financial Figures

Filing Documents

Forward-Looking Statements

Forward-Looking Statements Information provided and statements contained in this report that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements only speak as of the date of this report and the Registrant assumes no obligation to update the information included in this report. Such forward-looking statements include the expected use of proceeds from the offering. These statements often include words such as "may," "believe," "will," "expect," "project," "estimate," "anticipate," "plan," "initiative" or "continue." These forward-looking statements are not historical facts and are based on current expectations, estimates and projections about the Registrant's industry, management's beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond the Registrant's control. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance or occurrence of events and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Although the Registrant believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, results may prove to be materially different from the expectations expressed or implied by such forward-looking statements. More information about potential risks and uncertainties that could affect the Registrant's business and results of operations is included in the "Risk Factors" and "Forward-Looking Statements" sections in the Annual Report on Form 10-K filed by the Registrant with the Securities and Exchange Commission on February 14, 2025 and its other filings with the Securities and Exchange Commission. Unless otherwise required by law, the Registrant also disclaims any obligation to update i

Financial Statements and Exhibits

Financial Statements and Exhibits (d) Exhibits: Exhibit 99.1 Press Release, dated October 27, 2025 Exhibit 104 Cover Page Interactive Data File (embeded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HCA HEALTHCARE, INC. (Registrant) By: /s/ John M. Franck II John M. Franck II Vice President – Legal and Corporate Secretary Date: October 27, 2025

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing